Summary
• cbdMD, Inc. shares fell 5.7% in after-hours trading, closing at $0.5028.
• Preliminary results indicate year-over-year net sales will be consistent, but quarterly sales may increase by 3% to 5%.
• Stock performance shows a 78% decline over the past year, with trading volume significantly below average.
Shares of cbdMD, Inc. (YCBD) fell 5.7% in after-hours trading, bringing the current price to $0.5028, down from the last close of $0.533. The stock has experienced this decline without a defined catalyst.
Preliminary Financial Results Reported
On November 21, 2025, cbdMD released preliminary unaudited results for the fourth quarter and fiscal year ending September 30, 2025. Management expects year-over-year net sales to be consistent with the prior year, while quarterly net sales are projected to increase between 3% and 5%. Despite these insights, the lack of a fresh catalyst may have contributed to the stock’s downward trajectory today.
Market Performance Overview
The latest trading session continued to reflect the bearish trend for cbdMD, characterized by a significant drop in value over various timeframes. Over the past year, the stock has lost approximately 78% of its value, and its year-to-date performance currently sits at -73%. The stock’s technical indicators show an RSI of 22.33, suggesting that it is in oversold territory.
Trading volume in the after-hours session was recorded at 17,530, significantly below the stock’s 3-month average volume of 3,510,681 and the 10-day average of 217,847, indicating lower trading activity during this time.
Broader Market Trends and Technical Indicators
From a technical standpoint, cbdMD is experiencing challenges, with price trends showing substantial deviations from moving averages. The stock currently sits at -38.5% from its 20-day SMA, -49.0% from the 50-day SMA, and -66.0% from the 200-day SMA. This poses questions about the stock’s ability to regain upward momentum in the near term.
Despite the fall, analyst sentiment remains somewhat optimistic, with a “Buy” rating indicating potential for recovery. Market participants will be closely monitoring how the stock interacts with these technical benchmarks moving forward.
Monitoring Future Developments
With no fresh catalyst in play, the recent movements reflect routine market activity as traders evaluate short-term positioning. Investors will likely keep a watchful eye on future disclosures and sales performance as the financial landscape evolves for cbdMD.